Evidence map›Paper›PMID 31065023›Full record

ArticleScientific reports2019

Increased LIGHT expression and activation of non-canonical NF-κB are observed in gastric lesions of MyD88-deficient mice upon Helicobacter felis infection.

Raquel Mejías-Luque, Ivonne Lozano-Pope, Andreas Wanisch, Matthias Heikenwälder, Markus Gerhard, Marygorret Obonyo

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 22 citations in OpenAlex.

  1. Molecular surveillance ofOne health (Amsterdam, Netherlands) · 2024
    Article
  2. TRIF-IFN-I pathway iniScience · 2024
    Article
  3. Article
  4. Article
  5. Engagement of CEACAM1 byMicroorganisms · 2021
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Raquel Mejías-LuqueInstitute for Medical Microbiology, Immunology, and Hygiene, Technical University of Munich, School of Medicine, Munich, Germany.ORCID http://orcid.org/0000-0002-4602-4927
Ivonne Lozano-PopeDepartment of Medicine, School of Medicine, University of California, San Diego, La Jolla, California, USA.
Andreas WanischInstitute for Medical Microbiology, Immunology, and Hygiene, Technical University of Munich, School of Medicine, Munich, Germany.
Matthias HeikenwälderDivision of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Markus GerhardInstitute for Medical Microbiology, Immunology, and Hygiene, Technical University of Munich, School of Medicine, Munich, Germany.ORCID http://orcid.org/0000-0001-9110-3950
Marygorret ObonyoDepartment of Medicine, School of Medicine, University of California, San Diego, La Jolla, California, USA. mobonyo@ucsd.edu.
German Center for Infection Research · DEUniversity of California San Diego · USGerman Cancer Research Center · DE

Funding

MyD88-dependent mechanisms of Helicobacter pylori-induced gastric cancer progressionR21CA210227 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI OBONYO, MARYGORRET · 2017 to 2018
$371k
NCI NIH HHS R21 CA210227
6 · The paper itself

Abstract

Helicobacter pylori infection induces a number of pro-inflammatory signaling pathways contributing to gastric inflammation and carcinogenesis. Among those, NF-κB signaling plays a pivotal role during infection and malignant transformation of the gastric epithelium. However, deficiency of the adaptor molecule myeloid differentiation primary response 88 (MyD88), which signals through NF-κB, led to an accelerated development of gastric pathology upon H. felis infection, but the mechanisms leading to this phenotype remained elusive. Non-canonical NF-κB signaling was shown to aggravate H. pylori-induced gastric inflammation via activation of the lymphotoxin β receptor (LTβR). In the present study, we explored whether the exacerbated pathology observed in MyD88-deficient (Myd88

Indexed as

AnimalsB-LymphocytesChemokine CXCL9Helicobacter felisHelicobacter InfectionsIntercellular Adhesion Molecule-1MaleMice, Inbred C57BLMice, Mutant StrainsMyeloid Differentiation Factor 88NF-kappa BSignal TransductionSTAT3 Transcription FactorStomach DiseasesT-LymphocytesTumor Necrosis Factor Ligand Superfamily Member 14Chemokine CXCL9Cxcl9 protein, mouseIcam1 protein, mouseIntercellular Adhesion Molecule-1Myd88 protein, mouseMyeloid Differentiation Factor 88NF-kappa BStat3 protein, mouseSTAT3 Transcription FactorTnfsf14 protein, mouseTumor Necrosis Factor Ligand Superfamily Member 14

Identifiers

PMID31065023
PMCPMC6504916
OpenAlexW2943915255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.